Kura Oncology, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
KURA chart
What traders are saying about $KURA
Latest postsKura Oncology, Inc. news
- Form S-3ASR Kura Oncology Inc For: 10 November By Investing.com
Investing.com UK ·
- Earnings call transcript: Kura Oncology posts q3 2026 EPS beat, shares rise By Investing.com
Investing.com India ·
- Kura Oncology Releases Q3 2026 Financial Results
AlphaStreet ·
- Kura Oncology Inc earnings beat by $0.03, revenue fell short of estimates
Investing.com Nigeria ·
- Kura Oncology Q3 Loss Narrows, Revenue Rises
marketscreener.com ·
- Kura Oncology Reports Q3 2026 Loss of $0.78 Per Share on Revenue of $22.8 Million, Exceeding EPS Estimates
GuruFocus ·
- Kura Oncology, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Kura Oncology stock: Q3 revenue rises as KOMZIFTI sales expand
ad-hoc-news.de ·
- Kura Oncology announces third quarter 2026 financial results and updates on clinical programs
Traders Union ·
- Kura Oncology: Q3 Earnings Snapshot
Yahoo Finance ·
- Kura Oncology (KURA) Reports Q3 Loss, Beats Revenue Estimates
Yahoo Finance ·
- Revenue rose to $22.8M at Kura Oncology (KURA), but Q3 still ended in a loss.
Stock Titan ·
Kura Oncology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $67.5M | $53.9M | $0 | – |
| Net income | -$278.7M | -$174.0M | -$152.6M | -$135.8M |
| Diluted EPS | $-3.18 | $-2.02 | $-2.08 | $-2.03 |
| Total assets (year end) | $738.4M | $760.2M | $448.9M | $456.3M |
| Cash and equivalents (year end) | $149.1M | $224.5M | $37.3M | $51.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Kura Oncology, Inc.
- Ticker
- KURA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1422143
- Former names
- ZETA ACQUISITION CORP III
Frequently asked questions
What exchange is Kura Oncology, Inc. listed on?
Kura Oncology, Inc. trades on the Nasdaq under the ticker symbol KURA.
What industry is Kura Oncology, Inc. in?
Kura Oncology, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Kura Oncology, Inc. headquartered?
Kura Oncology, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Kura Oncology, Inc.'s fiscal year end?
Kura Oncology, Inc.'s fiscal year ends on December 31.
How much revenue did Kura Oncology, Inc. report?
Kura Oncology, Inc. reported $67.5M in revenue for calendar year 2025, according to its SEC filings.